Lista de obras - Dan Peer - Dominio Público Uruguay

A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes

scientific article published on 30 January 2020

A daunting task: manipulating leukocyte function with RNAi

artículo científico publicado en 2013

AL-57, a ligand-mimetic antibody to integrin LFA-1, reveals chemokine-induced affinity up-regulation in lymphocytes.

artículo científico publicado en 2006

Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles.

artículo científico publicado en 2016

Altering the immune response with lipid-based nanoparticles.

artículo científico publicado en 2011

An ovarian spheroid based tumor model that represents vascularized tumors and enables the investigation of nanomedicine therapeutics

artículo científico publicado en 2020

Antibody-mediated delivery of siRNAs for anti-HIV therapy

artículo científico publicado en 2011

Assessing cellular toxicities in fibroblasts upon exposure to lipid-based nanoparticles: a high content analysis approach ⬇️

artículo científico publicado el 21 de noviembre de 2011

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy

scientific article published on 18 November 2020

Cationic Amphiphilic Drugs Boost the Lysosomal Escape of Small Nucleic Acid Therapeutics in a Nanocarrier-Dependent Manner

scientific article published on 06 April 2020

Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes

scientific article published in Nature Communications

Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes.

artículo científico publicado en 2015

Colitis ImmunoPET: Defining Target Cell Populations and Optimizing Pharmacokinetics

artículo científico publicado en 2016

Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics

artículo científico publicado en 2021

Detection of intestinal inflammation by MicroPET imaging using a (64)Cu-labeled anti-beta(7) integrin antibody

artículo científico publicado en 2010

Dielectrophoretic characterization of cells in a stationary nanoliter droplet array with generated chemical gradients.

artículo científico publicado en 2015

Emerging Trends in Micro- and Nanoscale Technologies in Medicine: From Basic Discoveries to Translation.

artículo científico publicado en 2017

Enhanced bioavailability of polyaromatic hydrocarbons in the form of mucin complexes.

artículo científico publicado en 2011

Featuring the special issue guest editor: Dan Peer, Ph.D.

artículo científico

Focus on RNA interference: from nanoformulations to in vivo delivery

artículo científico publicado en 2017

Genetic perturbation of the putative cytoplasmic membrane-proximal salt bridge aberrantly activates alpha(4) integrins

artículo científico publicado en 2008

Grand challenges in modulating the immune response with RNAi nanomedicines.

artículo científico publicado en 2011

Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.

artículo científico publicado en 2015

Harnessing nanomedicine for mucosal theranostics--a silver bullet at last?

artículo científico publicado en 2013

Harnessing nanomedicine for therapeutic intervention in glioblastoma.

artículo científico publicado en 2016

Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells

artículo científico publicado en 2012

Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response.

artículo científico publicado en 2011

Hyaluronan-grafted particle clusters loaded with Mitomycin C as selective nanovectors for primary head and neck cancers ⬇️

artículo científico publicado el 11 de abril de 2011

IKAP/hELP1 down-regulation in neuroblastoma cells causes enhanced cell adhesion mediated by contactin overexpression.

artículo científico publicado en 2010

Immunomodulation of hematological malignancies using oligonucleotides based-nanomedicines.

artículo científico publicado en 2016

Induction of therapeutic gene silencing in leukocyte-implicated diseases by targeted and stabilized nanoparticles: a mini-review.

scientific article published on 17 July 2010

Integrin-targeted nanoparticles for siRNA delivery.

artículo científico publicado en 2012

Integrin-targeted stabilized nanoparticles for an efficient delivery of siRNAs in vitro and in vivo

artículo científico publicado en 2012

Investigation of pH-Responsiveness inside Lipid Nanoparticles for Parenteral mRNA Application Using Small-Angle X-ray Scattering

artículo científico publicado en 2020

Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory target

artículo científico publicado en 2019

Liposomes and other assemblies as drugs and nano-drugs: from basic and translational research to the clinics.

artículo científico publicado en 2012

Liposomes, lipid biophysics, and sphingolipid research: from basic to translation research

artículo científico publicado en 2012

Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles

artículo científico publicado en 2015

Metastability in lipid based particles exhibits temporally deterministic and controllable behavior

artículo científico publicado en 2015

Modulating cancer multidrug resistance by sertraline in combination with a nanomedicine

artículo científico publicado en 2014

Modulation of Immune Response Using Engineered Nanoparticle Surfaces.

artículo científico publicado en 2015

NT-09CO-DELIVERY OF siRNA AND CHEMOTHERAPY; A NEW APPROACH FOR GBM TREATMENT USING A NANOCARRIERS SYSTEM.

artículo científico publicado en 2014

Nanodiamonds of Laser Synthesis for Biomedical Applications

artículo científico publicado en 2015

Nanomedicine as an emerging platform for metastatic lung cancer therapy.

artículo científico

Nanoparticle hydrophobicity dictates immune response

artículo científico publicado en 2012

Nanotoxicity and the importance of being earnest

artículo científico publicado en 2012

Next-Generation Lipids in RNA Interference Therapeutics.

artículo científico publicado en 2017

Optimizing the biofabrication process of omentum-based scaffolds for engineering autologous tissues

artículo científico publicado en 2014

Overcoming multidrug resistance with nanomedicines

artículo científico

Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors.

artículo científico publicado en 2010

Platelet mimicry: The emperor's new clothes?

artículo científico publicado en 2015

Polysaccharides as building blocks for nanotherapeutics

artículo científico publicado en 2011

Precision medicine--delivering the goods?

artículo científico

Progress and challenges towards targeted delivery of cancer therapeutics.

artículo científico publicado en 2018

Providing the full picture: a mandate for standardizing nanoparticle-based drug delivery

artículo científico publicado en 2013

Quaternized starch-based carrier for siRNA delivery: from cellular uptake to gene silencing.

artículo científico publicado en 2014

RNA inhibition highlights cyclin D1 as a potential therapeutic target for mantle cell lymphoma

artículo científico publicado en 2012

RNA nanomedicines: the next generation drugs?

artículo científico publicado en 2016

RNAi nanomedicines: challenges and opportunities within the immune system.

artículo científico publicado en 2010

RNAi nanoparticles in the service of personalized medicine.

artículo científico publicado en 2009

RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice

artículo científico publicado en 2009

Reshaping the future of nanopharmaceuticals: ad iudicium.

artículo científico publicado en 2011

SNP detection in mRNA in living cells using allele specific FRET probes

artículo científico publicado en 2013

Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1.

artículo científico publicado en 2007

Serum chemokine network correlates with chemotherapy in non-small cell lung cancer

artículo científico publicado en 2015

Special delivery: targeted therapy with small RNAs.

artículo científico publicado en 2011

Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles

artículo científico publicado en 2015

Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target

artículo científico publicado en 2008

Targeting anthracycline-resistant tumor cells with synthetic aloe-emodin glycosides

artículo científico publicado en 2011

The human P-glycoprotein transporter enhances the type I interferon response to Listeria monocytogenes infection

artículo científico publicado en 2015

The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation.

artículo científico publicado en 2010

Therapeutic mRNA delivery to leukocytes

artículo científico publicado en 2019

Transforming Nanomedicines From Lab Scale Production to Novel Clinical Modality.

artículo científico publicado en 2016

Triggered-release polymeric conjugate micelles for on-demand intracellular drug delivery.

artículo científico publicado en 2015

Zooming in on selectins in cancer

artículo científico publicado en 2016

eIF3c: a potential therapeutic target for cancer

artículo científico publicado en 2013

siRNA delivery: current trends and future perspectives

artículo científico publicado en 2016

Lista de obras de Dan Peer

A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes

A daunting task: manipulating leukocyte function with RNAi

AL-57, a ligand-mimetic antibody to integrin LFA-1, reveals chemokine-induced affinity up-regulation in lymphocytes.

Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles.

Altering the immune response with lipid-based nanoparticles.

An ovarian spheroid based tumor model that represents vascularized tumors and enables the investigation of nanomedicine therapeutics

Antibody-mediated delivery of siRNAs for anti-HIV therapy

Assessing cellular toxicities in fibroblasts upon exposure to lipid-based nanoparticles: a high content analysis approach ⬇️

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy

Cationic Amphiphilic Drugs Boost the Lysosomal Escape of Small Nucleic Acid Therapeutics in a Nanocarrier-Dependent Manner

Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes

Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes.

Colitis ImmunoPET: Defining Target Cell Populations and Optimizing Pharmacokinetics

Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics

Detection of intestinal inflammation by MicroPET imaging using a (64)Cu-labeled anti-beta(7) integrin antibody

Dielectrophoretic characterization of cells in a stationary nanoliter droplet array with generated chemical gradients.

Emerging Trends in Micro- and Nanoscale Technologies in Medicine: From Basic Discoveries to Translation.

Enhanced bioavailability of polyaromatic hydrocarbons in the form of mucin complexes.

Featuring the special issue guest editor: Dan Peer, Ph.D.

Focus on RNA interference: from nanoformulations to in vivo delivery

Genetic perturbation of the putative cytoplasmic membrane-proximal salt bridge aberrantly activates alpha(4) integrins

Grand challenges in modulating the immune response with RNAi nanomedicines.

Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.

Harnessing nanomedicine for mucosal theranostics--a silver bullet at last?

Harnessing nanomedicine for therapeutic intervention in glioblastoma.

Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells

Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response.

Hyaluronan-grafted particle clusters loaded with Mitomycin C as selective nanovectors for primary head and neck cancers ⬇️

IKAP/hELP1 down-regulation in neuroblastoma cells causes enhanced cell adhesion mediated by contactin overexpression.

Immunomodulation of hematological malignancies using oligonucleotides based-nanomedicines.

Induction of therapeutic gene silencing in leukocyte-implicated diseases by targeted and stabilized nanoparticles: a mini-review.

Integrin-targeted nanoparticles for siRNA delivery.

Integrin-targeted stabilized nanoparticles for an efficient delivery of siRNAs in vitro and in vivo

Investigation of pH-Responsiveness inside Lipid Nanoparticles for Parenteral mRNA Application Using Small-Angle X-ray Scattering

Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory target

Liposomes and other assemblies as drugs and nano-drugs: from basic and translational research to the clinics.

Liposomes, lipid biophysics, and sphingolipid research: from basic to translation research

Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles

Metastability in lipid based particles exhibits temporally deterministic and controllable behavior

Modulating cancer multidrug resistance by sertraline in combination with a nanomedicine

Modulation of Immune Response Using Engineered Nanoparticle Surfaces.

NT-09CO-DELIVERY OF siRNA AND CHEMOTHERAPY; A NEW APPROACH FOR GBM TREATMENT USING A NANOCARRIERS SYSTEM.

Nanodiamonds of Laser Synthesis for Biomedical Applications

Nanomedicine as an emerging platform for metastatic lung cancer therapy.

Nanoparticle hydrophobicity dictates immune response

Nanotoxicity and the importance of being earnest

Next-Generation Lipids in RNA Interference Therapeutics.

Optimizing the biofabrication process of omentum-based scaffolds for engineering autologous tissues

Overcoming multidrug resistance with nanomedicines

Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors.

Platelet mimicry: The emperor's new clothes?

Polysaccharides as building blocks for nanotherapeutics

Precision medicine--delivering the goods?

Progress and challenges towards targeted delivery of cancer therapeutics.

Providing the full picture: a mandate for standardizing nanoparticle-based drug delivery

Quaternized starch-based carrier for siRNA delivery: from cellular uptake to gene silencing.

RNA inhibition highlights cyclin D1 as a potential therapeutic target for mantle cell lymphoma

RNA nanomedicines: the next generation drugs?

RNAi nanomedicines: challenges and opportunities within the immune system.

RNAi nanoparticles in the service of personalized medicine.

RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice

Reshaping the future of nanopharmaceuticals: ad iudicium.

SNP detection in mRNA in living cells using allele specific FRET probes

Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1.

Serum chemokine network correlates with chemotherapy in non-small cell lung cancer

Special delivery: targeted therapy with small RNAs.

Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles

Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target

Targeting anthracycline-resistant tumor cells with synthetic aloe-emodin glycosides

The human P-glycoprotein transporter enhances the type I interferon response to Listeria monocytogenes infection

The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation.

Therapeutic mRNA delivery to leukocytes

Transforming Nanomedicines From Lab Scale Production to Novel Clinical Modality.

Triggered-release polymeric conjugate micelles for on-demand intracellular drug delivery.

Zooming in on selectins in cancer

eIF3c: a potential therapeutic target for cancer

siRNA delivery: current trends and future perspectives